Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-15

Clinical Trial Update: Ivabradine to Improve Endothelial Function in Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ivabradine for improving endothelial function in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVABRADINE

Snippet

Sponsor: Campus Bio-Medico University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED